Category: Patent & Other IP Offices
-
Atlas Global at risk of losing four patents-in-suit against defendants including Acer, HP, TP-Link, Vantiva; already lost one definitively
Context: Atlas Global is enforcing WiFi patents acquired from Newracom, an ETRI spinoff, against various device makers in the Unified Patent Court (UPC) and in Germany. Last summer, the Oberlandesgericht MĂźnchen (Munich Higher Regional Court) raised the amount of collateral required for enforcement for âŹ4 million to âŹ26 million in an Atlas v. TP-Link case…
-
ToolGen sues Vertex, Lonza, and RoslinCT over CRISPR patents
ToolGenâs suits come in response to patent oppositions filed by the defendants over its first-ever European CRISPR-Cas9 protein delivery method patent.
-
Supercomputer firm ParTec seeks discretionary denial of Microsoft’s PTAB IPR petition under Acting USPTO Director’s new bifurcated framework
A dispute over the architecture of server clusters used for AI could give rise to one of the first high-profile discretionary denials under Acting Director Coke Morgan Stewart’s new rules.
-
Discretionary denials of PTAB inter partes reviews come back with a vengeance: Fintiv review inserted before potential merits proceedings
Within four weeks of her decision to rescind former USPTO Director Kathi Vidal’s memo narrowing the application of Fintiv, Acting Director Coke Morgan Stewart has taken another bold step favoring patentees.
-
EPO Patent Index 2024: Unitary Patent requests “exceeded expectations” despite stagnant European applications
The European Patent Officeâs Patent Index 2024 found that there was no growth in European applications (-0.1%) compared with 2023, although unitary protection was requested for 25.6% of all patents granted by the EPO in 2024 â a 53% increase compared to 2023.
-
Unified Patent Court injunction in 10x Genomics v. NanoString could be reinstated as EPO Opposition Division upholds patent in ‘slightly amended form’
Context: The Unified Patent Court (UPC) opened its doors on June 1, 2023, and only a few months later, in September 2023, 10x Genomics won a preliminary injunction against rival NanoString in the Munich Local Division (LD). NanoString nearly went out of business as a result of that loss, but apparently found an acquirer. The…
-
Gallium nitride patent wars: China’s Innoscience claims âultimate victoryâ in ITC litigation against EPCÂ
The United States Patent & Trademark Office has invalidated the only remaining patent in a United States International Trade Commission dispute initiated by Efficient Power Conversion over gallium nitride patents, handing Innoscience a significant win.
-
âSEPs are lifeâ but finite resources, geopolitical circumstances put proposed EU SEP Regulation on âtimeoutâ: European Commission’s Kamil KiljaĹski
Speaking at a SEP conference in Warsaw today, DG GROW IP deputy director Kamil KiljaĹski emphasized that the European Commissionâs decision to withdraw its proposed SEP regulation was only on a âtimeoutâ and that a large factor that contributed to this was a shift in geopolitical circumstances â in particular those in the U.S. and…
-
A âbreakthroughâ that may have gone âtoo farâ: fallout follows ECJâs cross-border jurisdiction ruling
European patent attorneys have largely welcomed a European Court of Justice decision allowing courts to rule on the infringement of U.S., UK, and other foreign patents (as well as award damages and injunctions). But those in foreign jurisdictions, such as China, are concerned that the ruling could lead to âsignificant chaosâ and that the court…
-
Japanâs Nippon Shinyaku vows to fight on in U.S. drug dispute against Sarepta Therapeutics, despite heavy $115 million blow
The Japanese pharma company initiated the drug patent litigation in 2021, but the case eventually boomeranged and a District of Delaware verdict last week ultimately handed Sarepta the win.